Incidence of Post-operative Vomitings (POV) After Early Refeeding in Pediatric Day Case Surgery.

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02288650

Enrollment

808

Registered

2014-11-11

Start date

2013-07-31

Completion date

Unknown

Last updated

2014-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediatric Day Case Surgery, Post-operative Vomiting Incidence

Brief summary

At the child, the post-operative vomitings (POV) remain the main post-operative complication in term of frequency. They also represent the first cause of unforeseen hospitalization in day case surgery. The causes of POV are multiple, including in particular the post-operative prescription of opioids. The role of the premature refeeding remains discussed. Up to the age of 4 years, acute pain is difficult to distinguish from other causes of distress (anxiety, anger but also hunger) being able to make prescribe wrongly opioids in post-operative. The main objective of this study is to estimate the POV in pediatric day case surgery after early refeeding with clear liquids in the recovery room or only in the day case wards (usual practice). The secondary objectives are to estimate the time on returning to the day case ward, at home, the post-operative opioid consumption, early refeeding adverse effects (desaturation, swallowing trouble)

Interventions

OTHERearly refeeding

OTHERrefeeding only in the recovery room (usual practice).

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

3 Months to 4 Years

Healthy volunteers

Inclusion criteria

* Patient of less than 4 years old * A pediatric day case surgery scheduled

Exclusion criteria

* Child lower age or 3 month old equal * Premature child of conceptional age lower than 60 weeks * Anesthetic or surgical constraint dissuading day case surgery or early refeeding * Digestive pathology predisposing to the VPO (Hernia hiatal, gastro-oesophageal reflux) * treatment interfering with emesis (imidazoles, neuroleptic) * Period of exclusion defined by another study

Design outcomes

Primary

Measure	Time frame
Time between withdrawal of orotracheal tube and POV	The participant are followed for 3 days.

Countries

France

Contacts

Primary ContactChloé CHAUVIN, Doctor

Chloe.CHAUVIN@chru-strasbourg.fr3 12 70 89

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 10, 2026